EUVIMEDEUVIMED entdecken
Crossref

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries

Marisa Nishio iD, Hiromi Sugiyama iD, Valerie McCormack iD, Jérôme Viguier, Bruno Quesnel, Juan Iovanna iD, Nelson Dusetti iD, Pascal Hammel, Marie-Charlotte Henrion, Cecilia Monge iD, Tara McKay, Alice Chen iD und 7 weitere

JCO Global Oncology · 2026-04 · 12 (4)

DOI: 10.1200/go-25-00483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2026-04. Verfasst von Marisa Nishio und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE In 2023, the G7 Cancer Initiative was launched by Australia, Canada, France, Germany, Japan, the United Kingdom, and the United States with the aim of enhancing global cancer control, and with poor-prognosis cancers as a priority. To facilitate effective collaboration among G7 Cancer, we aimed to address the lack of standardized definitions and coordinated initiatives across countries. METHODS We examined how the G7 Cancer Initiative countries defined poor-prognosis cancers, objectively classified them, quantified their burden, and assessed national response strategies. A review of national cancer plans was conducted together with an expert email survey to evaluate definitions and classifications. Poor-prognosis cancers were identified based on 5-year net survival (NS) below 30% and a mortality-to-incidence (M/I) ratio over 0.75 using CONCORD-3 and Global Cancer Observatory 2022 data. RESULTS Pancreatic cancer was consistently categorized as a poor-prognosis cancer, while some countries also included liver, esophageal, stomach, and some brain cancers. For lung cancer, classification varied depending on the definition used. These six cancers accounted for a major share of cancer deaths, with lung (18%-23%) and pancreatic (6%-10%) cancers contributing the most. National strategies differed, with Australia, France, and Japan implementing specific policies for poor-prognosis cancers, while others addressed them indirectly or not at all. CONCLUSION To enhance cancer outcomes for poor-prognosis cancers, the G7 Cancer Initiative should coordinate efforts through joint programs focused on early detection, treatment, and policy alignment. Standardized definitions and collaborative action are essential to strengthening the global poor-prognosis cancer response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansPrognosisJapanAustraliaUnited StatesHealth Policy

Autor:innen und Institutionen

  • Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Department of Medical Statistics, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Department of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
  • International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.
  • Institut National du Cancer-French National Cancer Institute, Paris, France.
  • Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

ORCID-Profile: Marisa Nishio, Hiromi Sugiyama, Valerie McCormack, Juan Iovanna, Nelson Dusetti, Cecilia Monge, Alice Chen, Karol Nowicki-Osuch, Mayo Hirabayashi, Marina Tanitame, Tetsuya Tajima, Manami Inoue, Tomohiro Matsuda

Förderung

  • World Health Organization

Zitieren

APA

Nishio, M., Sugiyama, H., McCormack, V., Viguier, J., Quesnel, B., Iovanna, J., Dusetti, N., Hammel, P., Henrion, M. C., Monge, C., McKay, T., Chen, A., Nowicki-Osuch, K., Abe, S., Hirabayashi, M., Tanitame, M., Tajima, T., Inoue, M., & Matsuda, T. (2026). Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries. JCO Global Oncology, 12(4). https://doi.org/10.1200/go-25-00483

Vancouver

Nishio M, Sugiyama H, McCormack V, Viguier J, Quesnel B, Iovanna J, et al. Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries. JCO Global Oncology. 2026;12(4). doi:10.1200/go-25-00483

BibTeX
@article{Nishio2026,
  author = {Nishio, Marisa and Sugiyama, Hiromi and McCormack, Valerie and Viguier, Jérôme and Quesnel, Bruno and Iovanna, Juan and Dusetti, Nelson and Hammel, Pascal and Henrion, Marie-Charlotte and Monge, Cecilia and McKay, Tara and Chen, Alice and Nowicki-Osuch, Karol and Abe, Sarah and Hirabayashi, Mayo and Tanitame, Marina and Tajima, Tetsuya and Inoue, Manami and Matsuda, Tomohiro},
  title = {Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries},
  journal = {JCO Global Oncology},
  year = {2026},
  volume = {12},
  number = {4},
  doi = {10.1200/go-25-00483}
}
Kostenlos starten →